Interim order on preventing and alleviating drug shortages in relation to COVID-19: Notice

Date published: October 19, 2020

The Interim Order Respecting the Prevention and Alleviation of Shortages of Drugs in Relation to Covid-19 was signed on October 16, 2020. This interim order (IO) provides more tools for urgently addressing drug shortages related to COVID-19.

Under certain conditions, the IO authorizes the Minister of Health to:

On this page

Why the interim order was introduced

The COVID-19 pandemic has:

How the interim order will address drug shortages in Canada

Reliable and timely information is required for Health Canada to act quickly and effectively to minimize the effects of these shortages on Canadians. Tools such as this new IO will better prepare Canada to respond to the imminent threat of drug shortages from a possible future resurgence of COVID-19.

The IO will allow the Minister to require any person who sells a drug to provide information about a shortage or potential shortage of that drug. The IO gives the Minister this authority if there are reasonable grounds to believe that:

To prevent or alleviate a shortage, the Minister may also add or amend terms and conditions to an authorization to sell a drug. The Minister may do so if there are reasonable grounds to believe that:

If you have any questions, please contact us by email at:

Related links and guidance

Page details

Date modified: